ZERIGO HEALTH
Clarify Medical is innovating a well-established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients. The company also focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions. Clarify Medical indicated for the localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic ... dermatitis, and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress, and satisfaction.
ZERIGO HEALTH
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Medical Medical Device Therapeutics
Founded:
2014-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.zerigohealth.com
Total Employee:
11+
Status:
Active
Contact:
877 738 6041
Email Addresses:
[email protected]
Total Funding:
67.41 M USD
Technology used in webpage:
SSL By Default Content Delivery Network Domain Not Resolving Nginx Euro Amazon ReCAPTCHA JsDelivr BootstrapCDN Cloudflare Hosting
Current Advisors List
Current Employees Featured
Founder
Investors List
Leverage Health
Leverage Health investment in Series B - Zerigo Health
General Catalyst
General Catalyst investment in Series B - Zerigo Health
H.I.G. Capital
H.I.G. Capital investment in Series B - Zerigo Health
Bluestem Capital
Bluestem Capital investment in Series B - Zerigo Health
Cigna Ventures
Cigna Ventures investment in Series B - Zerigo Health
Leaps by Bayer
Leaps by Bayer investment in Series B - Zerigo Health
SV Health Investors
SV Health Investors investment in Series B - Zerigo Health
7wire Ventures
7wire Ventures investment in Series B - Zerigo Health
Dragoneer Investment Group
Dragoneer Investment Group investment in Series B - Zerigo Health
Bluestem Capital
Bluestem Capital investment in Series A - Zerigo Health
Newest Events participated
Participated in TMCx Summer 2015 Demo Day
on 2015-09-10 as exhibitor
Official Site Inspections
http://www.zerigohealth.com Semrush global rank: 5.54 M Semrush visits lastest month: 1.53 K
- Host name: server-108-138-85-16.iad12.r.cloudfront.net
- IP address: 108.138.85.16
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
